New guidelines expand the categories of high-risk children eligible for respiratory syncytial virus (RSV) vaccination and address COVID-19 vaccines for children in two policy statements and accompanying technical reports from the American Academy of Pediatrics (AAP), published online Sept. 2 in Pediatrics.
AAP Expands RSV Vaccination Guidelines for High-Risk Children Ahead of 2026-2027 Season
The American Academy of Pediatrics (AAP) has issued new guidelines expanding RSV vaccination eligibility for high-risk children and addressing COVID-19 vaccinations for children. This update is significant for pediatric health policies in various countries, including Iran, as it may influence vaccination strategies and public health initiatives. The recommendations were published on September 2 in the journal Pediatrics.
👥 Key Players
📰 What Happened
The AAP has released new guidelines that expand the categories of high-risk children eligible for RSV vaccination and address COVID-19 vaccinations for children. These updates aim to improve pediatric health outcomes.
- The guidelines were published on September 2 in the journal Pediatrics.
- They specifically target high-risk children, which may include those with underlying health conditions.
💡 Why It Matters
📚 Background
Respiratory syncytial virus (RSV) is a common respiratory virus that can be serious for infants and young children, particularly those with health vulnerabilities. Vaccination is a key strategy to prevent severe illness.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%